Analyst Kyle Boucher from TD Cowen has identified Bio-Techne (TECH) as a prime small to mid-cap investment for 2026, reiterating a Buy rating with a $65 target price despite a recent 4% stock decline. The company, which specializes in biotechnology reagents and diagnostic products, is seen as undervalued, with anticipated market improvements expected to boost its performance by fiscal year 2027. While Bio-Techne boasts a strong GF Score of 83 and robust financial health, its high P/E ratio and recent insider selling suggest investors should proceed with caution and monitor upcoming market conditions.

The global botanical extracts industry is experiencing rapid growth, driven by increasing consumer demand for natural and plant-based ingredients in various sectors like food, cosmetics, and pharmaceuticals. Valued at USD 7.32 billion in 2025, the market is projected to reach USD 17.00 billion by 2033, exhibiting an 11.18% CAGR. This article highlights the top ten companies shaping this market, emphasizing their contributions through sustainable practices, innovative extraction technologies, and extensive research and development.

UnitedHealth Group maintains a strong analyst consensus on the NYSE, with several firms raising their price targets in June. The stock is currently trading around $406 per share, below many updated targets, with its next earnings report scheduled for mid-July. Analysts are focusing on the performance of the Optum health services unit and medical cost trends from UnitedHealthcare.

Provident Bank has appointed Adriano Duarte as Executive Vice President and Chief Financial Officer for both Provident Bank and Provident Financial Services, Inc., effective July 1, 2026. Duarte, who joined Provident in 2020 and previously served as Chief Accounting Officer, will oversee the bank's finance organization. He succeeds Thomas Lyons, who retired, and brings over 30 years of banking and financial services experience to the role.

Peachtree Group has partnered with Goldman Sachs Custody Solutions to make its alternative investment offerings more accessible to registered investment advisors (RIAs) and their clients. This collaboration will allow Peachtree's real estate and credit strategies to be available on the GSCS platform, providing institutional-grade custody with streamlined access and operations. The move expands Peachtree's distribution channels for its over $10 billion in committed capital under management.

Deutsche Bank has initiated coverage on DexCom Inc. (NASDAQ:DXCM) with a Buy rating and a price target of $86.00, citing strong continuous glucose monitoring (CGM) market growth and easing concerns about revenue durability. The stock is considered significantly undervalued, and the expansion of CMS coverage for Type 2 non-insulin users is expected to double DexCom's covered lives by 2027, driving further upside.

Deutsche Bank has initiated coverage on Insulet Corporation (NASDAQ:PODD) with a Buy rating and a $190.00 price target, noting the stock is undervalued and nearing its 52-week low. Despite potential competitive headwinds from tubeless insulin pumps and GLP-1 medications, the bank sees an attractive growth profile, robust growth algorithms, and expects shares to rebound as selling pressure exhausts. Recent product updates, FDA clearance for Omnipod 5 enhancements, and clinical trial data were also highlighted, alongside a revised negative outlook from Moody's and mixed analyst sentiment from Benchmark and Truist Securities.

Regions Bank has appointed Lisa Phillips as Consumer Banking Executive for Georgia and the Carolinas, and Mia Hubbard as Retail Service Delivery Manager for its entire branch network. These leadership changes aim to enhance business growth in key Southeastern markets and improve service consistency across the bank's 15-state footprint, focusing on personalized service and community engagement. The appointments are effective July 6, with both leaders bringing extensive experience to their new roles.

Deutsche Bank has initiated coverage on Smurfit Westrock (NYSE:SW) with a Buy rating and a $57.00 price target, citing the company's potential for margin expansion. The bank highlights the value creation opportunity from combining Smurfit Kappa's operational discipline with WestRock's North American asset base, expecting the rollout of an owner-operator model to drive significant Adjusted EBITDA growth by 2030. Despite a mixed Q1 2026 earnings report and the cancellation of its secondary LSE listing, Deutsche Bank projects approximately 30% total return for the stock, including a 4.0% dividend yield.

International Paper (NYSE: IP) will release its second-quarter 2026 earnings on July 30, 2026, before the NYSE opens, followed by a webcast discussion at 10:00 a.m. ET. The announcement confirms the earnings call timing and access details, with previous earnings-date notices historically showing small, mixed one-day stock movements. The company is a leader in sustainable packaging solutions.